{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T09:46:59Z","timestamp":1785923219190,"version":"3.56.0"},"reference-count":99,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Zhejiang Province Traditional Chinese Medicine Science and Technology Project","award":["2026094589"],"award-info":[{"award-number":["2026094589"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urogynecol J"],"DOI":"10.1007\/s00192-026-06836-9","type":"journal-article","created":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T09:18:24Z","timestamp":1785921504000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Neuromodulation for Lower Urinary Tract Dysfunction: Mechanisms, Modalities, and Patient Selection"],"prefix":"10.1007","author":[{"given":"Yukun","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinlin","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Engeng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,5]]},"reference":[{"issue":"1","key":"6836_CR1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/iju.12009","volume":"20","author":"WC de Groat","year":"2013","unstructured":"de Groat WC. Lower urinary tract dysfunction: From basic science to clinical management. Foreword Int J Urol. 2013;20(1):3. https:\/\/doi.org\/10.1111\/iju.12009","journal-title":"Foreword. Int J Urol"},{"issue":"7","key":"6836_CR2","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/s41585-024-00967-8","volume":"22","author":"J Krhut","year":"2025","unstructured":"Krhut J, Kobbero H, Kanaan R, Fode M, Poulsen M, Zvara P. The mechanism of action of neuromodulation in the treatment of overactive bladder. Nat Rev Urol. 2025;22(7):414\u201326. https:\/\/doi.org\/10.1038\/s41585-024-00967-8","journal-title":"Nat Rev Urol"},{"key":"6836_CR3","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.17870","volume":"12","author":"S Pang","year":"2024","unstructured":"Pang S, Yan J. Research and progress on the mechanism of lower urinary tract neuromodulation: a literature review. PeerJ. 2024;12:e17870. https:\/\/doi.org\/10.7717\/peerj.17870","journal-title":"PeerJ"},{"issue":"1","key":"6836_CR4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1080\/17434440.2017.1268913","volume":"14","author":"JA Cohn","year":"2017","unstructured":"Cohn JA, Kowalik CG, Kaufman MR, Reynolds WS, Milam DF, Dmochowski RR. Evaluation of the axonics modulation technologies sacral neuromodulation system for the treatment of urinary and fecal dysfunction. Expert Rev Med Devices. 2017;14(1):3\u201314. https:\/\/doi.org\/10.1080\/17434440.2017.1268913","journal-title":"Expert Rev Med Devices"},{"issue":"5","key":"6836_CR5","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1016\/j.juro.2015.01.087","volume":"193","author":"Gormley EA, Lightner DJ, Faraday M, Vasavada SP, American Urological A, Society of Urodynamics FPM","year":"2015","unstructured":"Gormley EA, Lightner DJ, Faraday M, Vasavada SP, American Urological A, Society of Urodynamics FPM. Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA\/SUFU guideline amendment. J Urol. 2015;193(5):1572\u201380. https:\/\/doi.org\/10.1016\/j.juro.2015.01.087","journal-title":"J Urol"},{"issue":"1","key":"6836_CR6","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.juro.2017.07.010","volume":"199","author":"S Siegel","year":"2018","unstructured":"Siegel S, Noblett K, Mangel J, Bennett J, Griebling TL, Sutherland SE, et al. Five-year followup results of a prospective, multicenter study of patients with overactive bladder treated with sacral neuromodulation. J Urol. 2018;199(1):229\u201336.","journal-title":"J Urol"},{"issue":"3","key":"6836_CR7","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.neurom.2024.09.003","volume":"28","author":"RR Dutta","year":"2025","unstructured":"Dutta RR, Abdolmanafi S, Rabizadeh A, Baghbaninogourani R, Mansooridara S, Lopez A, et al. Neuromodulation and disorders of consciousness: systematic review and pathophysiology. Neuromodulation. 2025;28(3):380\u2013400. https:\/\/doi.org\/10.1016\/j.neurom.2024.09.003","journal-title":"Neuromodulation"},{"issue":"41","key":"6836_CR8","doi-asserted-by":"publisher","first-page":"2403562","DOI":"10.1002\/adfm.202403562","volume":"34","author":"S Oh","year":"2024","unstructured":"Oh S, Jekal J, Liu J, Kim J, Park JU, Lee T, et al. Bioelectronic Implantable Devices for Physiological Signal Recording and Closed-Loop Neuromodulation. Adv Funct Mater. 2024;34(41):2403562. https:\/\/doi.org\/10.1002\/adfm.202403562","journal-title":"Advanced Functional Materials"},{"issue":"5","key":"6836_CR9","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1016\/j.wneu.2015.06.040","volume":"84","author":"SC Park","year":"2015","unstructured":"Park SC, Lee CS, Lee JK. Rechargeable battery: the essential tool for the new era of neuromodulation. World Neurosurg. 2015;84(5):1198\u2013200. https:\/\/doi.org\/10.1016\/j.wneu.2015.06.040","journal-title":"World Neurosurg"},{"issue":"6","key":"6836_CR10","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1016\/j.euf.2022.04.006","volume":"8","author":"L Liao","year":"2022","unstructured":"Liao L, Zhou Z, Chen G, Xu Z, Huang B, Chong T, et al. Sacral neuromodulation using a novel device with a six\u2013contact-point electrode for the treatment of patients with refractory overactive bladder: a multicenter, randomized, single-blind, parallel-control clinical trial. Eur Urol Focus. 2022;8(6):1823\u201330. https:\/\/doi.org\/10.1016\/j.euf.2022.04.006","journal-title":"Eur Urol Focus"},{"key":"6836_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12103490","author":"C McPhail","year":"2023","unstructured":"McPhail C, Carey R, Nambiar S, Willison N, Bahadori S, Aryan P, et al. The investigation of percutaneous tibial nerve stimulation (PTNS) as a minimally invasive, non-surgical, non-hormonal treatment for overactive bladder symptoms. J Clin Med. 2023. https:\/\/doi.org\/10.3390\/jcm12103490","journal-title":"J Clin Med"},{"issue":"7","key":"6836_CR12","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1002\/nau.25477","volume":"43","author":"J Heesakkers","year":"2024","unstructured":"Heesakkers J, Toozs-Hobson P, Sutherland SE, Digesu A, Amundsen CL, McCrery RJ, et al. A prospective study to assess the effectiveness and safety of the BlueWind system in the treatment of patients diagnosed with urgency urinary incontinence. Neurourol Urodyn. 2024;43(7):1491\u2013503. https:\/\/doi.org\/10.1002\/nau.25477","journal-title":"Neurourol Urodyn"},{"key":"6836_CR13","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.16356.1","author":"A Downey","year":"2019","unstructured":"Downey A, Inman RD. Recent advances in surgical management of urinary incontinence. F1000Res. 2019. https:\/\/doi.org\/10.12688\/f1000research.16356.1","journal-title":"F1000Res"},{"key":"6836_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.cont.2025.102308","author":"HJ Kendall","year":"2025","unstructured":"Kendall HJ, Dmochowski RR, Heesakkers JPFA. Predictive factors of clinical success for treatment of urgency urinary incontinence using implantable tibial neuromodulation. Continence. 2025. https:\/\/doi.org\/10.1016\/j.cont.2025.102308","journal-title":"Continence"},{"issue":"3","key":"6836_CR15","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.81121","volume":"17","author":"V Lucente","year":"2025","unstructured":"Lucente V, Morrisroe S, Schiff W, Barber N. A prospective study on the effectiveness of sensory and sub-sensory stimulation amplitudes using eCoin(R) implantable tibial nerve stimulation in reducing urgency urinary incontinence episodes and enhancing quality of life. Cureus. 2025;17(3):e81121. https:\/\/doi.org\/10.7759\/cureus.81121","journal-title":"Cureus"},{"issue":"1","key":"6836_CR16","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s12325-024-03019-0","volume":"42","author":"CL Amundsen","year":"2025","unstructured":"Amundsen CL, Sutherland SE, Kielb SJ, Dmochowski RR. Sacral and implantable tibial neuromodulation for the management of overactive bladder: a systematic review and meta-analysis. Adv Ther. 2025;42(1):10\u201335. https:\/\/doi.org\/10.1007\/s12325-024-03019-0","journal-title":"Adv Ther"},{"issue":"2","key":"6836_CR17","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1007\/s40122-021-00298-1","volume":"10","author":"AD Kaye","year":"2021","unstructured":"Kaye AD, Ridgell S, Alpaugh ES, Mouhaffel A, Kaye AJ, Cornett EM, et al. Peripheral nerve stimulation: a review of techniques and clinical efficacy. Pain Ther. 2021;10(2):961\u201372. https:\/\/doi.org\/10.1007\/s40122-021-00298-1","journal-title":"Pain Ther"},{"issue":"4","key":"6836_CR18","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1093\/bjaceaccp\/mkp021","volume":"9","author":"I Jones","year":"2009","unstructured":"Jones I, Johnson MI. Transcutaneous electrical nerve stimulation. Contin Educ Anaesth Crit Care Pain. 2009;9(4):130\u20135. https:\/\/doi.org\/10.1093\/bjaceaccp\/mkp021","journal-title":"Contin Educ Anaesth Crit Care Pain"},{"issue":"4","key":"6836_CR19","doi-asserted-by":"publisher","DOI":"10.1002\/wnan.1890","volume":"15","author":"X Lu","year":"2023","unstructured":"Lu X, Li G, Jiao W, Li K, Zhang T, Liu X, et al. Magnetic nanomaterials-mediated neuromodulation. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2023;15(4):e1890. https:\/\/doi.org\/10.1002\/wnan.1890","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"issue":"2","key":"6836_CR20","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1002\/nau.24601","volume":"40","author":"H O'Sullivan","year":"2021","unstructured":"O\u2019Sullivan H, Kelly G, Toale J, Cascio S. Comparing the outcomes of parasacral transcutaneous electrical nerve stimulation for the treatment of lower urinary tract dysfunction in children: a systematic review and meta-analysis of randomized controlled trials. Neurourol Urodyn. 2021;40(2):570\u201381. https:\/\/doi.org\/10.1002\/nau.24601","journal-title":"Neurourol Urodyn"},{"key":"6836_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/toxins12020128","author":"CW Lo","year":"2020","unstructured":"Lo CW, Wu MY, Yang SS, Jaw FS, Chang SJ. Comparing the efficacy of onabotulinumtoxinA, sacral neuromodulation, and peripheral tibial nerve stimulation as third line treatment for the management of overactive bladder symptoms in adults: systematic review and network meta-analysis. Toxins (Basel). 2020. https:\/\/doi.org\/10.3390\/toxins12020128","journal-title":"Toxins (Basel)"},{"issue":"13","key":"6836_CR22","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1001\/jama.2016.14617","volume":"316","author":"CL Amundsen","year":"2016","unstructured":"Amundsen CL, Richter HE, Menefee SA, Komesu YM, Arya LA, Gregory WT, et al. OnabotulinumtoxinA vs sacral neuromodulation on refractory urgency urinary incontinence in women: a randomized clinical trial. JAMA. 2016;316(13):1366\u201374. https:\/\/doi.org\/10.1001\/jama.2016.14617","journal-title":"JAMA"},{"issue":"6","key":"6836_CR23","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nrn2401","volume":"9","author":"CJ Fowler","year":"2008","unstructured":"Fowler CJ, Griffiths D, de Groat WC. The neural control of micturition. Nat Rev Neurosci. 2008;9(6):453\u201366. https:\/\/doi.org\/10.1038\/nrn2401","journal-title":"Nat Rev Neurosci"},{"issue":"1","key":"6836_CR24","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/cphy.c130056","volume":"5","author":"WC de Groat","year":"2015","unstructured":"de Groat WC, Griffiths D, Yoshimura N. Neural control of the lower urinary tract. Compr Physiol. 2015;5(1):327\u201396. https:\/\/doi.org\/10.1002\/cphy.c130056","journal-title":"Compr Physiol"},{"issue":"1","key":"6836_CR25","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.cell.2020.02.054","volume":"181","author":"SM Won","year":"2020","unstructured":"Won SM, Song E, Reeder JT, Rogers JA. Emerging modalities and implantable technologies for neuromodulation. Cell. 2020;181(1):115\u201335. https:\/\/doi.org\/10.1016\/j.cell.2020.02.054","journal-title":"Cell"},{"issue":"8","key":"6836_CR26","doi-asserted-by":"publisher","first-page":"2480","DOI":"10.1002\/nau.23742","volume":"37","author":"H Chen","year":"2018","unstructured":"Chen H, Zeng J, Zeng P, Jiang C, Xie K, Lindstrom S. Repeat periods of electrical stimulation prolong the modulation of the micturition reflex in the rat. Neurourol Urodyn. 2018;37(8):2480\u20136. https:\/\/doi.org\/10.1002\/nau.23742","journal-title":"Neurourol Urodyn"},{"key":"6836_CR27","doi-asserted-by":"publisher","DOI":"10.1097\/UPJ.0000000000000916","author":"MAZ Ball","year":"2025","unstructured":"Ball MAZ, Cheng MYZ, Mbassa R, Meeks W, Galen E, Van Kuiken ME. Trends in utilization of sacral neuromodulation for overactive bladder: insight from the AUA AQUA registry. Urol Pract. 2025. https:\/\/doi.org\/10.1097\/UPJ.0000000000000916","journal-title":"Urol Pract"},{"issue":"1","key":"6836_CR28","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1097\/spv.0000000000001254","volume":"29","author":"M Torosis","year":"2023","unstructured":"Torosis M, Jackson N, Nitti V, Ackerman AL. Overactive bladder patients with and without urgency incontinence: a spectrum of one condition or different phenotypes? Urogynecology (Phila). 2023;29(1):33\u201340. https:\/\/doi.org\/10.1097\/spv.0000000000001254","journal-title":"Urogynecology (Phila)"},{"issue":"1","key":"6836_CR29","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1097\/ju.0000000000002939","volume":"209","author":"HH Lai","year":"2023","unstructured":"Lai HH, Wiseman JB, Helmuth ME, Smith AR, Amundsen CL, Cameron AP, et al. Phenotyping of urinary urgency patients without urgency incontinence, and their comparison to urgency incontinence patients: findings from the LURN study. J Urol. 2023;209(1):233\u201342. https:\/\/doi.org\/10.1097\/ju.0000000000002939","journal-title":"J Urol"},{"issue":"12","key":"6836_CR30","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/ncpuro1251","volume":"5","author":"TM Kessler","year":"2008","unstructured":"Kessler TM, Fowler CJ. Sacral neuromodulation for urinary retention. Nat Clin Pract Urol. 2008;5(12):657\u201366. https:\/\/doi.org\/10.1038\/ncpuro1251","journal-title":"Nat Clin Pract Urol"},{"issue":"12","key":"6836_CR31","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/nrurol.2015.266","volume":"12","author":"D Griffiths","year":"2015","unstructured":"Griffiths D. Neural control of micturition in humans: a working model. Nat Rev Urol. 2015;12(12):695\u2013705. https:\/\/doi.org\/10.1038\/nrurol.2015.266","journal-title":"Nat Rev Urol"},{"key":"6836_CR32","doi-asserted-by":"publisher","first-page":"535","DOI":"10.3389\/fnins.2019.00535","volume":"13","author":"HA Roy","year":"2019","unstructured":"Roy HA, Green AL. The central autonomic network and regulation of bladder function. Front Neurosci. 2019;13:535. https:\/\/doi.org\/10.3389\/fnins.2019.00535","journal-title":"Front Neurosci"},{"issue":"4","key":"6836_CR33","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s00345-011-0780-2","volume":"30","author":"PE Van Kerrebroeck","year":"2012","unstructured":"Van Kerrebroeck PE, Marcelissen TA. Sacral neuromodulation for lower urinary tract dysfunction. World J Urol. 2012;30(4):445\u201350. https:\/\/doi.org\/10.1007\/s00345-011-0780-2","journal-title":"World J Urol"},{"issue":"1","key":"6836_CR34","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1097\/JU.0000000000003985","volume":"212","author":"AP Cameron","year":"2024","unstructured":"Cameron AP, Chung DE, Dielubanza EJ, Enemchukwu E, Ginsberg DA, Helfand BT, et al. The AUA\/SUFU guideline on the diagnosis and treatment of idiopathic overactive bladder. J Urol. 2024;212(1):11\u201320. https:\/\/doi.org\/10.1097\/JU.0000000000003985","journal-title":"J Urol"},{"key":"6836_CR35","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004202.pub2","volume":"2","author":"GP Herbison","year":"2009","unstructured":"Herbison GP, Arnold EP. Sacral neuromodulation with implanted devices for urinary storage and voiding dysfunction in adults. Cochrane Database Syst Rev. 2009;2:CD004202. https:\/\/doi.org\/10.1002\/14651858.CD004202.pub2","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"6836_CR36","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1097\/JU.0000000000000309","volume":"202","author":"DJ Lightner","year":"2019","unstructured":"Lightner DJ, Gomelsky A, Souter L, Vasavada SP. Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA\/SUFU guideline amendment 2019. J Urol. 2019;202(3):558\u201363. https:\/\/doi.org\/10.1097\/JU.0000000000000309","journal-title":"J Urol"},{"issue":"11","key":"6836_CR37","doi-asserted-by":"publisher","DOI":"10.1056\/EVIDoa2200071","volume":"1","author":"MD Liechti","year":"2022","unstructured":"Liechti MD, Lely Svd, Kn\u00fcpfer SC, Abt D, Kiss B, Leitner L, et al. Sacral neuromodulation for neurogenic lower urinary tract dysfunction. NEJM Evid. 2022;1(11):EVIDoa2200071. https:\/\/doi.org\/10.1056\/EVIDoa2200071","journal-title":"NEJM Evid"},{"issue":"5","key":"6836_CR38","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1097\/JU.0000000000002235","volume":"206","author":"DA Ginsberg","year":"2021","unstructured":"Ginsberg DA, Boone TB, Cameron AP, Gousse A, Kaufman MR, Keays E, et al. The AUA\/SUFU guideline on adult neurogenic lower urinary tract dysfunction: diagnosis and evaluation. J Urol. 2021;206(5):1097\u2013105. https:\/\/doi.org\/10.1097\/JU.0000000000002235","journal-title":"J Urol"},{"issue":"5","key":"6836_CR39","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1097\/JU.0000000000002239","volume":"206","author":"DA Ginsberg","year":"2021","unstructured":"Ginsberg DA, Boone TB, Cameron AP, Gousse A, Kaufman MR, Keays E, et al. The AUA\/SUFU guideline on adult neurogenic lower urinary tract dysfunction: treatment and follow-up. J Urol. 2021;206(5):1106\u201313. https:\/\/doi.org\/10.1097\/JU.0000000000002239","journal-title":"J Urol"},{"issue":"4","key":"6836_CR40","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1097\/MOU.0b013e3283476ea2","volume":"21","author":"DM Daly","year":"2011","unstructured":"Daly DM, Collins VM, Chapple CR, Grundy D. The afferent system and its role in lower urinary tract dysfunction. Curr Opin Urol. 2011;21(4):268\u201374. https:\/\/doi.org\/10.1097\/MOU.0b013e3283476ea2","journal-title":"Curr Opin Urol"},{"issue":"6","key":"6836_CR41","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1111\/j.1464-410X.2006.06521.x","volume":"98","author":"BF Blok","year":"2006","unstructured":"Blok BF, Groen J, Bosch JL, Veltman DJ, Lammertsma AA. Different brain effects during chronic and acute sacral neuromodulation in urge incontinent patients with implanted neurostimulators. BJU Int. 2006;98(6):1238\u201343. https:\/\/doi.org\/10.1111\/j.1464-410X.2006.06521.x","journal-title":"BJU Int"},{"issue":"2","key":"6836_CR42","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/sc.2015.124","volume":"54","author":"J Wollner","year":"2016","unstructured":"Wollner J, Krebs J, Pannek J. Sacral neuromodulation in patients with neurogenic lower urinary tract dysfunction. Spinal Cord. 2016;54(2):137\u201340. https:\/\/doi.org\/10.1038\/sc.2015.124","journal-title":"Spinal Cord"},{"issue":"6","key":"6836_CR43","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/j.eururo.2010.09.024","volume":"58","author":"TM Kessler","year":"2010","unstructured":"Kessler TM, La Framboise D, Trelle S, Fowler CJ, Kiss G, Pannek J, et al. Sacral neuromodulation for neurogenic lower urinary tract dysfunction: systematic review and meta-analysis. Eur Urol. 2010;58(6):865\u201374. https:\/\/doi.org\/10.1016\/j.eururo.2010.09.024","journal-title":"Eur Urol"},{"key":"6836_CR44","doi-asserted-by":"publisher","unstructured":"Groen J, Pannek J, Castro Diaz D, Del Popolo G, Gross T, Hamid R, Karsenty G, Kessler TM, Schneider M, t Hoen L, Blok B (2016) Summary of European Association of Urology (EAU) Guidelines on Neuro-Urology. Eur Urol 69 (2):324-333. https:\/\/doi.org\/10.1016\/j.eururo.2015.07.071","DOI":"10.1016\/j.eururo.2015.07.071"},{"issue":"6","key":"6836_CR45","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.eururo.2024.03.026","volume":"85","author":"AM Sartori","year":"2024","unstructured":"Sartori AM, Kessler TM, Castro-D\u00edaz DM, de Keijzer P, Del Popolo G, Ecclestone H, et al. Summary of the 2024 update of the European Association of Urology Guidelines on Neuro-urology. Eur Urol. 2024;85(6):543\u201355.","journal-title":"Eur Urol"},{"issue":"1","key":"6836_CR46","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1097\/JU.0000000000002756","volume":"208","author":"JQ Clemens","year":"2022","unstructured":"Clemens JQ, Erickson DR, Varela NP, Lai HH. Diagnosis and treatment of interstitial cystitis\/bladder pain syndrome. J Urol. 2022;208(1):34\u201342.","journal-title":"J Urol"},{"issue":"8","key":"6836_CR47","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1111\/j.1464-410X.2010.09697.x","volume":"107","author":"JB Gajewski","year":"2011","unstructured":"Gajewski JB, Al-Zahrani AA. The long-term efficacy of sacral neuromodulation in the management of intractable cases of bladder pain syndrome: 14 years of experience in one centre. BJU Int. 2011;107(8):1258\u201364. https:\/\/doi.org\/10.1111\/j.1464-410X.2010.09697.x","journal-title":"BJU Int"},{"key":"6836_CR48","doi-asserted-by":"publisher","DOI":"10.1177\/17562872221135941","volume":"14","author":"B Padilla-Fernandez","year":"2022","unstructured":"Padilla-Fernandez B, Hernandez-Hernandez D, Castro-Diaz DM. Current role of neuromodulation in bladder pain syndrome\/interstitial cystitis. Ther Adv Urol. 2022;14:17562872221135941. https:\/\/doi.org\/10.1177\/17562872221135941","journal-title":"Ther Adv Urol"},{"issue":"11","key":"6836_CR49","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14113647","volume":"14","author":"M Rekatsina","year":"2025","unstructured":"Rekatsina M, Leoni MLG, Visser-Vandewalle V, Mercieri M, Varrassi G, Matis G. Long-term outcomes of sacral neuromodulation for refractory interstitial cystitis\/bladder pain syndrome: a retrospective cohort study. J Clin Med. 2025;14(11):3647. https:\/\/doi.org\/10.3390\/jcm14113647","journal-title":"J Clin Med"},{"issue":"1","key":"6836_CR50","doi-asserted-by":"publisher","first-page":"11031","DOI":"10.1038\/s41598-017-11062-x","volume":"7","author":"J Wang","year":"2017","unstructured":"Wang J, Chen Y, Chen J, Zhang G, Wu P. Sacral neuromodulation for refractory bladder pain syndrome\/interstitial cystitis: a global systematic review and meta-analysis. Sci Rep. 2017;7(1):11031. https:\/\/doi.org\/10.1038\/s41598-017-11062-x","journal-title":"Sci Rep"},{"issue":"3","key":"6836_CR51","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1002\/nau.22544","volume":"34","author":"S Siegel","year":"2015","unstructured":"Siegel S, Noblett K, Mangel J, Griebling TL, Sutherland SE, Bird ET, et al. Results of a prospective, randomized, multicenter study evaluating sacral neuromodulation with InterStim therapy compared to standard medical therapy at 6-months in subjects with mild symptoms of overactive bladder. Neurourol Urodyn. 2015;34(3):224\u201330.","journal-title":"Neurourol Urodyn"},{"issue":"5","key":"6836_CR52","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1016\/j.juro.2007.07.032","volume":"178","author":"PE van Kerrebroeck","year":"2007","unstructured":"van Kerrebroeck PE, van Voskuilen AC, Heesakkers JP, Lycklama \u00e1 Nijholt AA, Siegel S, Jonas U, et al. Results of sacral neuromodulation therapy for urinary voiding dysfunction: outcomes of a prospective, worldwide clinical study. J Urol. 2007;178(5):2029\u201334.","journal-title":"J Urol"},{"issue":"1","key":"6836_CR53","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1002\/nau.24583","volume":"40","author":"S Gandhi","year":"2021","unstructured":"Gandhi S, Gajewski JB, Koziarz A, Almutairi S, Ali A, Cox A. Long-term outcomes of sacral neuromodulation for lower urinary tract dysfunction: a 23-year experience. Neurourol Urodyn. 2021;40(1):461\u20139. https:\/\/doi.org\/10.1002\/nau.24583","journal-title":"Neurourol Urodyn"},{"issue":"2","key":"6836_CR54","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1080\/17434440.2022.2032655","volume":"19","author":"S Tilborghs","year":"2022","unstructured":"Tilborghs S, De Wachter S. Sacral neuromodulation for the treatment of overactive bladder: systematic review and future prospects. Expert Rev Med Devices. 2022;19(2):161\u201387. https:\/\/doi.org\/10.1080\/17434440.2022.2032655","journal-title":"Expert Rev Med Devices"},{"issue":"5","key":"6836_CR55","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1002\/nau.24376","volume":"39","author":"K Benson","year":"2020","unstructured":"Benson K, McCrery R, Taylor C, Padron O, Blok B, de Wachter S, et al. One-year outcomes of the ARTISAN-SNM study with the Axonics system for the treatment of urinary urgency incontinence. Neurourol Urodyn. 2020;39(5):1482\u20138. https:\/\/doi.org\/10.1002\/nau.24376","journal-title":"Neurourol Urodyn"},{"issue":"8","key":"6836_CR56","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1002\/nau.24756","volume":"40","author":"X Huang","year":"2021","unstructured":"Huang X, Jiang GJ. Magnetic resonance imaging interactions with a sacral neuromodulation system. Neurourol Urodyn. 2021;40(8):1862\u20138. https:\/\/doi.org\/10.1002\/nau.24756","journal-title":"Neurourol Urodyn"},{"issue":"4","key":"6836_CR57","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1002\/nau.24317","volume":"39","author":"B Blok","year":"2020","unstructured":"Blok B, Van Kerrebroeck P, de Wachter S, Ruffion A, Van der Aa F, Perrouin-Verbe MA, et al. Two-year safety and efficacy outcomes for the treatment of overactive bladder using a long-lived rechargeable sacral neuromodulation system. Neurourol Urodyn. 2020;39(4):1108\u201314. https:\/\/doi.org\/10.1002\/nau.24317","journal-title":"Neurourol Urodyn"},{"issue":"2","key":"6836_CR58","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1002\/nau.23892","volume":"38","author":"B Blok","year":"2019","unstructured":"Blok B, Van Kerrebroeck P, de Wachter S, Ruffion A, Van der Aa F, Jairam R, et al. A prospective, multicenter study of a novel, miniaturized rechargeable sacral neuromodulation system: 12-month results from the RELAX-OAB study. Neurourol Urodyn. 2019;38(2):689\u201395. https:\/\/doi.org\/10.1002\/nau.23892","journal-title":"Neurourol Urodyn"},{"issue":"4","key":"6836_CR59","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1016\/j.juro.2009.12.036","volume":"183","author":"KM Peters","year":"2010","unstructured":"Peters KM, Carrico DJ, Perez-Marrero RA, Khan AU, Wooldridge LS, Davis GL, et al. Randomized trial of percutaneous tibial nerve stimulation versus Sham efficacy in the treatment of overactive bladder syndrome: results from the SUmiT trial. J Urol. 2010;183(4):1438\u201343. https:\/\/doi.org\/10.1016\/j.juro.2009.12.036","journal-title":"J Urol"},{"issue":"1","key":"6836_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.rehab.2021.101486","volume":"65","author":"R Sonmez","year":"2022","unstructured":"Sonmez R, Yildiz N, Alkan H. Efficacy of percutaneous and transcutaneous tibial nerve stimulation in women with idiopathic overactive bladder: a prospective randomised controlled trial. Ann Phys Rehabil Med. 2022;65(1):101486. https:\/\/doi.org\/10.1016\/j.rehab.2021.101486","journal-title":"Ann Phys Rehabil Med"},{"issue":"2","key":"6836_CR61","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1002\/nau.23351","volume":"37","author":"J Booth","year":"2018","unstructured":"Booth J, Connelly L, Dickson S, Duncan F, Lawrence M. The effectiveness of transcutaneous tibial nerve stimulation (TTNS) for adults with overactive bladder syndrome: a systematic review. Neurourol Urodyn. 2018;37(2):528\u201341. https:\/\/doi.org\/10.1002\/nau.23351","journal-title":"Neurourol Urodyn"},{"issue":"10","key":"6836_CR62","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1111\/iju.14961","volume":"29","author":"MS Alomari","year":"2022","unstructured":"Alomari MS, Abdulhamid AS, Ghaddaf AA, Alshareef KM, Haneef AK, AlQuhaibi MS, et al. Non-inferior and more feasible transcutaneous tibial nerve stimulation in treating overactive bladder: a systematic review and meta-analysis. Int J Urol. 2022;29(10):1170\u201380. https:\/\/doi.org\/10.1111\/iju.14961","journal-title":"Int J Urol"},{"key":"6836_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.cont.2025.102293","volume":"16","author":"HJ Kendall","year":"2025","unstructured":"Kendall HJ, Smits MAC, Martens FMJ, Heesakkers JPFA. Feasibility of replacing a tibial nerve neuromodulation implant. A case series. Continence. 2025;16:102293. https:\/\/doi.org\/10.1016\/j.cont.2025.102293","journal-title":"Continence"},{"issue":"3","key":"6836_CR64","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1097\/JU.0000000000004328","volume":"213","author":"JP Heesakkers","year":"2025","unstructured":"Heesakkers JP, Toozs-Hobson P, Sutherland SE, Digesu A, Amundsen CL, McCrery RJ, et al. Two-year efficacy and safety outcomes of the pivotal OASIS study using the Revi system for treatment of urgency urinary incontinence. J Urol. 2025;213(3):323\u201332.","journal-title":"J Urol"},{"issue":"1","key":"6836_CR65","doi-asserted-by":"publisher","first-page":"82","DOI":"10.5173\/ceju.2023.86","volume":"77","author":"S Parodi","year":"2024","unstructured":"Parodi S, Kendall HJ, Terrone C, Heesakkers JP. Evolving types of pudendal neuromodulation for lower urinary tract dysfunction. Cent European J Urol. 2024;77(1):82\u20138. https:\/\/doi.org\/10.5173\/ceju.2023.86","journal-title":"Cent European J Urol"},{"key":"6836_CR66","doi-asserted-by":"publisher","first-page":"145","DOI":"10.2147\/RRU.S124981","volume":"9","author":"LL de Wall","year":"2017","unstructured":"de Wall LL, Heesakkers JP. Effectiveness of percutaneous tibial nerve stimulation in the treatment of overactive bladder syndrome. Res Rep Urol. 2017;9:145\u201357. https:\/\/doi.org\/10.2147\/RRU.S124981","journal-title":"Res Rep Urol"},{"key":"6836_CR67","doi-asserted-by":"publisher","DOI":"10.1002\/nau.70082","author":"Z Yang","year":"2025","unstructured":"Yang Z, Liao J, Zhang S, Zhang M, Qiao L. Effectiveness of extracorporeal magnetic stimulation in the treatment of pelvic floor dysfunction: a systematic review and meta\u2010analysis. Neurourol Urodyn. 2025. https:\/\/doi.org\/10.1002\/nau.70082","journal-title":"Neurourol Urodyn"},{"issue":"6","key":"6836_CR68","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1016\/j.juro.2012.11.175","volume":"189","author":"KM Peters","year":"2013","unstructured":"Peters KM, Carrico DJ, Wooldridge LS, Miller CJ, MacDiarmid SA. Percutaneous tibial nerve stimulation for the long-term treatment of overactive bladder: 3-year results of the STEP study. J Urol. 2013;189(6):2194\u2013201. https:\/\/doi.org\/10.1016\/j.juro.2012.11.175","journal-title":"J Urol"},{"key":"6836_CR69","doi-asserted-by":"publisher","first-page":"1014291","DOI":"10.3389\/fmed.2022.1014291","volume":"9","author":"P Liu","year":"2022","unstructured":"Liu P, Li Y, Shi B, Zhang Q, Guo H. Comparison of different types of therapy for overactive bladder: a systematic review and network meta-analysis. Front Med (Lausanne). 2022;9:1014291. https:\/\/doi.org\/10.3389\/fmed.2022.1014291","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"6836_CR70","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.juro.2017.07.010","volume":"199","author":"S Siegel","year":"2018","unstructured":"Siegel S, Noblett K, Mangel J, Bennett J, Griebling TL, Sutherland SE, et al. Five-year followup results of a prospective, multicenter study of patients with overactive bladder treated with sacral neuromodulation. J Urol. 2018;199(1):229\u201336. https:\/\/doi.org\/10.1016\/j.juro.2017.07.010","journal-title":"J Urol"},{"issue":"4","key":"6836_CR71","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1007\/s12325-021-01650-9","volume":"38","author":"A van Ophoven","year":"2021","unstructured":"van Ophoven A, Engelberg S, Lilley H, Sievert KD. Systematic literature review and meta-analysis of sacral neuromodulation (SNM) in patients with neurogenic lower urinary tract dysfunction (nLUTD): over 20 years\u2019 experience and future directions. Adv Ther. 2021;38(4):1987\u20132006. https:\/\/doi.org\/10.1007\/s12325-021-01650-9","journal-title":"Adv Ther"},{"issue":"2","key":"6836_CR72","doi-asserted-by":"publisher","first-page":"139","DOI":"10.5152\/tud.2024.23232","volume":"50","author":"DC Ochoa","year":"2024","unstructured":"Ochoa DC, Mahoney AC, Fontaine C, Hashim H. Guidelines of guidelines: conservative, pharmacological, and surgical management for neurogenic lower urinary tract dysfunction. Urol Res Pract. 2024;50(2):139\u201347. https:\/\/doi.org\/10.5152\/tud.2024.23232","journal-title":"Urol Res Pract"},{"issue":"11","key":"6836_CR73","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.73626","volume":"16","author":"A Akpala","year":"2024","unstructured":"Akpala A, Lezama T, Jinadu K, Belal M, King T. A five-year retrospective study on the clinical outcomes of sacral nerve stimulation for neuromodulation of the lower urinary tract in a tertiary hospital. Cureus J Med Sci. 2024;16(11):e73626. https:\/\/doi.org\/10.7759\/cureus.73626","journal-title":"Cureus J Med Sci"},{"key":"6836_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.cont.2025.102060","volume":"15","author":"S Sutherland","year":"2025","unstructured":"Sutherland S, Heesakkers J, Ferrante K, Dmochowski R. 136 - Quality-of-life outcomes of implantable tibial neuromodulation for urgency urinary incontinence: two year results from the OASIS pivotal study using the Revi system. Continence (Oxford). 2025;15:102060. https:\/\/doi.org\/10.1016\/j.cont.2025.102060","journal-title":"Continence (Oxford)"},{"issue":"4","key":"6836_CR75","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1002\/nau.25167","volume":"42","author":"J Greig","year":"2023","unstructured":"Greig J, Mak Q, Furrer MA, Sahai A, Raison N. Sacral neuromodulation in the management of chronic pelvic pain: a systematic review and meta-analysis. Neurourol Urodyn. 2023;42(4):822\u201336. https:\/\/doi.org\/10.1002\/nau.25167","journal-title":"Neurourol Urodyn"},{"issue":"5","key":"6836_CR76","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1007\/s00192-019-04186-3","volume":"31","author":"AA Bhide","year":"2020","unstructured":"Bhide AA, Tailor V, Fernando R, Khullar V, Digesu GA. Posterior tibial nerve stimulation for overactive bladder-techniques and efficacy. Int Urogynecol J. 2020;31(5):865\u201370. https:\/\/doi.org\/10.1007\/s00192-019-04186-3","journal-title":"Int Urogynecol J"},{"issue":"8","key":"6836_CR77","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1007\/s40266-020-00777-8","volume":"37","author":"C Shaw","year":"2020","unstructured":"Shaw C, Wagg A. Overactive bladder in frail older adults. Drugs Aging. 2020;37(8):559\u201365. https:\/\/doi.org\/10.1007\/s40266-020-00777-8","journal-title":"Drugs Aging"},{"issue":"4","key":"6836_CR78","doi-asserted-by":"publisher","first-page":"310","DOI":"10.12809\/hkmj2310921","volume":"30","author":"WKK Wong","year":"2024","unstructured":"Wong WKK, Kan RWM, Lam PS, Cheung PMH, Cheng EYL, Pun TCT, et al. Management of overactive bladder: consensus statements from the Hong Kong Urological Association and the Hong Kong Geriatrics Society. Hong Kong Med J. 2024;30(4):310\u20139. https:\/\/doi.org\/10.12809\/hkmj2310921","journal-title":"Hong Kong Med J"},{"issue":"8","key":"6836_CR79","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1007\/s00192-023-05492-7","volume":"34","author":"A Antic","year":"2023","unstructured":"Antic A, Pavcnik M, Lukanovic A, Matjasic M, Lukanovic D. Magnetic stimulation in the treatment of female urgency urinary incontinence: a systematic review. Int Urogynecol J. 2023;34(8):1669\u201376. https:\/\/doi.org\/10.1007\/s00192-023-05492-7","journal-title":"Int Urogynecol J"},{"key":"6836_CR80","doi-asserted-by":"publisher","DOI":"10.1016\/j.cont.2024.101705","volume":"12","author":"E Huri","year":"2024","unstructured":"Huri E, Hashim H, Zillioux J, Averbeck MA, McAchran S, Goldman H. Sacral neuromodulation update in 2024: insights from the ICS workshop 2023. Continence. 2024;12:101705. https:\/\/doi.org\/10.1016\/j.cont.2024.101705","journal-title":"Continence"},{"issue":"10","key":"6836_CR81","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1007\/s11934-018-0837-5","volume":"19","author":"CR Powell","year":"2018","unstructured":"Powell CR. Troubleshooting InterStim sacral neuromodulation generators to recover function. Curr Urol Rep. 2018;19(10):86. https:\/\/doi.org\/10.1007\/s11934-018-0837-5","journal-title":"Curr Urol Rep"},{"issue":"3","key":"6836_CR82","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1097\/JU.0000000000001024","volume":"204","author":"MJT Dorsthorst","year":"2020","unstructured":"Dorsthorst MJT, Digesu GA, Tailor V, Gore M, van Kerrebroeck PE, van Breda HMK, et al. 3-Year Followup of a new implantable tibial nerve stimulator for the treatment of overactive bladder syndrome. J Urol. 2020;204(3):545\u201350. https:\/\/doi.org\/10.1097\/JU.0000000000001024","journal-title":"J Urol"},{"issue":"7","key":"6836_CR83","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s11934-020-00980-5","volume":"21","author":"A Vollstedt","year":"2020","unstructured":"Vollstedt A, Gilleran J. Update on implantable PTNS devices. Curr Urol Rep. 2020;21(7):28. https:\/\/doi.org\/10.1007\/s11934-020-00980-5","journal-title":"Curr Urol Rep"},{"issue":"1","key":"6836_CR84","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1002\/nau.22266","volume":"32","author":"KM Peters","year":"2013","unstructured":"Peters KM, Carrico DJ, MacDiarmid SA, Wooldridge LS, Khan AU, McCoy CE, et al. Sustained therapeutic effects of percutaneous tibial nerve stimulation: 24-month results of the STEP study. Neurourol Urodyn. 2013;32(1):24\u20139. https:\/\/doi.org\/10.1002\/nau.22266","journal-title":"Neurourol Urodyn"},{"issue":"8","key":"6836_CR85","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1002\/nau.25248","volume":"42","author":"CE Carlton","year":"2023","unstructured":"Carlton CE, Souders CP, Chertack NA, Goueli RS, Lemack GE, Anger JT, et al. Understanding a decade of safety reporting for sacral neuromodulation in the Food and Drug Administration Manufacturer and User Facility Device Experience database. Neurourol Urodyn. 2023;42(8):1655\u201367. https:\/\/doi.org\/10.1002\/nau.25248","journal-title":"Neurourol Urodyn"},{"key":"6836_CR86","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2021.712168","volume":"15","author":"GE Gmel","year":"2021","unstructured":"Gmel GE, Vollebregt PF, Thijssen MEG, Santos Escapa R, McAlees E, Mugan D, et al. Electrophysiological responses in the human S3 nerve during sacral neuromodulation for fecal incontinence. Front Neurosci. 2021;15:712168. https:\/\/doi.org\/10.3389\/fnins.2021.712168","journal-title":"Front Neurosci"},{"issue":"1","key":"6836_CR87","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s42234-023-00134-1","volume":"10","author":"EM Versantvoort","year":"2024","unstructured":"Versantvoort EM, Dietz BE, Mugan D, Vuong QC, Luli S, Obara I. Evoked compound action potential (ECAP)-controlled closed-loop spinal cord stimulation in an experimental model of neuropathic pain in rats. Bioelectron Med. 2024;10(1):2. https:\/\/doi.org\/10.1186\/s42234-023-00134-1","journal-title":"Bioelectron Med"},{"issue":"6","key":"6836_CR88","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.biopsych.2023.09.014","volume":"95","author":"C Zrenner","year":"2024","unstructured":"Zrenner C, Ziemann U. Closed-loop brain stimulation. Biol Psychiatry. 2024;95(6):545\u201352. https:\/\/doi.org\/10.1016\/j.biopsych.2023.09.014","journal-title":"Biol Psychiatry"},{"key":"6836_CR89","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1109\/TNSRE.2021.3117518","volume":"29","author":"SJ Majerus","year":"2021","unstructured":"Majerus SJ, Offutt SJ, Brink TS, Vasoli V, Mcadams I, Damaser MS, et al. Feasibility of real-time conditional sacral neuromodulation using wireless bladder pressure sensor. IEEE Trans Neural Syst Rehabil Eng. 2021;29:2067\u201375.","journal-title":"IEEE Trans Neural Syst Rehabil Eng"},{"issue":"6","key":"6836_CR90","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1109\/TNSRE.2019.2912374","volume":"27","author":"Z Ouyang","year":"2019","unstructured":"Ouyang Z, Sperry ZJ, Barrera ND, Bruns TM. Real-time bladder pressure estimation for closed-loop control in a detrusor overactivity model. IEEE Trans Neural Syst Rehabil Eng. 2019;27(6):1209\u201316. https:\/\/doi.org\/10.1109\/TNSRE.2019.2912374","journal-title":"IEEE Trans Neural Syst Rehabil Eng"},{"key":"6836_CR91","unstructured":"Suskind M, Takacs E, Welk B, Smith AL, Souter L, Rahimi LL (2024) The AUA\/SUFU Guideline on the Diagnosis and Treatment of Idiopathic Overactive Bladder (2024). https:\/\/www.auanet.org\/guidelines-and-quality\/guidelines\/idiopathic-overactive-bladder"},{"issue":"5","key":"6836_CR92","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1007\/s00192-021-05040-1","volume":"33","author":"R Moussa","year":"2022","unstructured":"Moussa R, Rada MP, Durnea C, Falconi G, Betschart C, Haddad JM, et al. Outcome reporting in randomized controlled trials (RCTs) on the pharmacological management of idiopathic overactive bladder (OAB) in women; a systematic review for the development of core outcome sets (COS). Int Urogynecol J. 2022;33(5):1243\u201350. https:\/\/doi.org\/10.1007\/s00192-021-05040-1","journal-title":"Int Urogynecol J"},{"issue":"3","key":"6836_CR93","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.eururo.2008.06.047","volume":"54","author":"CR Chapple","year":"2008","unstructured":"Chapple CR, Khullar V, Gabriel Z, Muston D, Bitoun CE, Weinstein D. The effects of antimuscarinic treatments in overactive bladder: an update of a systematic review and meta-analysis. Eur Urol. 2008;54(3):543\u201362. https:\/\/doi.org\/10.1016\/j.eururo.2008.06.047","journal-title":"Eur Urol"},{"issue":"12","key":"6836_CR94","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1007\/s00192-017-3481-6","volume":"28","author":"C Foust-Wright","year":"2017","unstructured":"Foust-Wright C, Wissig S, Stowell C, Olson E, Anderson A, Anger J, et al. Development of a core set of outcome measures for OAB treatment. Int Urogynecol J. 2017;28(12):1785\u201393.","journal-title":"Int Urogynecol J"},{"issue":"1","key":"6836_CR95","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/nau.20798","volume":"29","author":"BT Haylen","year":"2010","unstructured":"Haylen BT, De Ridder D, Freeman RM, Swift SE, Berghmans B, Lee J, et al. An International Urogynecological Association (IUGA)\/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Neurourol Urodyn. 2010;29(1):4\u201320.","journal-title":"Neurourol Urodyn"},{"issue":"3","key":"6836_CR96","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s00192-018-3841-x","volume":"30","author":"A Khunda","year":"2019","unstructured":"Khunda A, McCormick C, Ballard P. Sacral neuromodulation and sexual function: a systematic review and meta-analysis of the literature. Int Urogynecol J. 2019;30(3):339\u201352. https:\/\/doi.org\/10.1007\/s00192-018-3841-x","journal-title":"Int Urogynecol J"},{"issue":"1","key":"6836_CR97","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.ucl.2004.09.001","volume":"32","author":"A Hijaz","year":"2005","unstructured":"Hijaz A, Vasavada S. Complications and troubleshooting of sacral neuromodulation therapy. Urol Clin North Am. 2005;32(1):65\u20139. https:\/\/doi.org\/10.1016\/j.ucl.2004.09.001","journal-title":"Urol Clin North Am"},{"issue":"12","key":"6836_CR98","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1007\/s00192-020-04429-8","volume":"31","author":"M Wang","year":"2020","unstructured":"Wang M, Jian Z, Ma Y, Jin X, Li H, Wang K. Percutaneous tibial nerve stimulation for overactive bladder syndrome: a systematic review and meta-analysis. Int Urogynecol J. 2020;31(12):2457\u201371. https:\/\/doi.org\/10.1007\/s00192-020-04429-8","journal-title":"Int Urogynecol J"},{"issue":"2","key":"6836_CR99","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1097\/JU.0000000000001733","volume":"206","author":"A Rogers","year":"2021","unstructured":"Rogers A, Bragg S, Ferrante K, Thenuwara C, Peterson DK. Pivotal study of leadless tibial nerve stimulation with eCoin\u00ae for urgency urinary incontinence: an open-label, single arm trial. J Urol. 2021;206(2):399\u2013408.","journal-title":"J Urol"}],"container-title":["International Urogynecology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-026-06836-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00192-026-06836-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-026-06836-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T09:18:27Z","timestamp":1785921507000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00192-026-06836-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,5]]},"references-count":99,"alternative-id":["6836"],"URL":"https:\/\/doi.org\/10.1007\/s00192-026-06836-9","relation":{},"ISSN":["0937-3462","1433-3023"],"issn-type":[{"value":"0937-3462","type":"print"},{"value":"1433-3023","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,5]]},"assertion":[{"value":"26 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval and institutional review board approval were not required for this review article because the study did not involve human participants, identifiable personal data, animal experiments, or the collection of new clinical data.","order":1,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","label":"Conflicts of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}